Douglas K. Bratton is 10% Owner at Denali Therapeutics Inc. (DNLI). They have made 6 open-market trades across 2 companies since 2014, most recently 2024-12-02.
2 open-market purchases totalling $19.9M since 2014, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DNLI | SELL | 2021-02-12 | 2021-02-17 | $65.00 | $144.1M | +5.1% | +0.8% | -9.8% |
| DNLI | SELL | 2020-06-19 | 2020-06-23 | $24.69 | $11.0M | -1.8% | -9.9% | +40.1% |
| DNLI | BUY | 2017-12-12 | 2017-12-14 | $18.00 | $5.0M | -17.7% | -11.2% | +13.7% |
| JUNO | SELL | 2015-07-02 | 2015-07-02 | $54.75 | $2.2M | -18.7% | +1.3% | +1.3% |
| JUNO | SELL | 2015-06-23 | 2015-06-25 | $51.13 | $13.8M | -18.7% | +1.3% | +1.3% |
| JUNO | BUY | 2014-12-23 | 2014-12-24 | $24.00 | $15.0M | -18.7% | +1.3% | +1.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.